Brief: New Data Show Strong Performance Of Veracyte’S Afirma Gsc In Real-World Clinical Practice
20/06/2022 13:36
June 20 (Reuters) - Veracyte Inc VCYT.O :
* NEW DATA SHOW STRONG PERFORMANCE OF VERACYTE’S AFIRMA GSC
IN
REAL-WORLD CLINICAL PRACTICE
Source text for Eikon: ID:nBw9CwQZPa
Further company coverage: VCYT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Veracyte
See all newsU.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina